Johnson & Johnson Innovative Medicine
Beerse · Founded 1953
About Johnson & Johnson Innovative Medicine
Johnson & Johnson Innovative Medicine focuses on developing medications to address a range of health conditions. This company works on creating treatments that target various diseases, aiming to improve patient outcomes through scientific research. Their efforts center on transforming lab discoveries into practical solutions for healthcare needs. The organization collaborates with medical professionals to ensure that therapies reach those who require them. Additionally, Johnson & Johnson Innovative Medicine explores new approaches to tackle complex health challenges. Their portfolio includes products designed for different therapeutic areas, reflecting a commitment to diverse medical solutions. This dedication to innovation helps shape options available in the healthcare sector.
Company Facts
- Founded: 1953
- Operating status: Acquired
- Company type: For Profit
- IPO status: Private
- Employees: 10,001+
- Estimated revenue: $10M+
- Funding stage: M&A
- Last round: Seed (Jan 2017)
- Website: jnj.cominnovativemedicine
- Phone: +32 (0)14 60 21 11
Social Profiles
Canonical: https://fsome.com/organization/johnson-johnson-innovative-medicine-8350715 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.